SCHEMBL6538372

SCHEMBL6538372

CCOC(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1N1CCOCC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.66
TP53 P04637 3/20 0.66
USP2 O75604 2/20 0.66
HSD17B10 Q99714 2/20 0.66
RECQL P46063 1/20 0.66
PKM P14618 1/20 0.65
POLB P06746 2/20 0.57
SMN1; SMN2 Q16637 3/20 0.55
MAPT P10636 4/20 0.51
LMNA P02545 4/20 0.51
ALDH1A1 P00352 3/20 0.51
HTT P42858 3/20 0.51
GAA P10253 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
ADORA1 P30542 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537773 0.90 LMNA (0.64) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6537716 0.87 HSD17B10 (0.52) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6537691 0.86 HSD17B10 (0.50) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6537601 0.86 HSD17B10 (0.49) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6537721 0.85 SMN1; SMN2 (0.52) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6537641 0.84 HSD17B10 (0.54) MAPK1TP53USP2HSD17B10RECQL
SCHEMBL6538111 0.82 KMT2A (0.58) TP53POLBSMN1; SMN2MAPTALDH1A1
SCHEMBL6537629 0.82 MAPT (0.50) TP53POLBSMN1; SMN2MAPTALDH1A1
SCHEMBL6537564 0.81 MEN1 (0.48) TP53USP2HSD17B10POLBSMN1; SMN2
SCHEMBL6537853 0.81 CYP1A2 (0.46) MAPK1TP53USP2HSD17B10RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed